Literature DB >> 9375277

Evaluation and treatment of speech and swallowing disorders associated with myopathies.

B C Sonies1.   

Abstract

Dysphagia, or disordered swallowing, can be demonstrated at any time over the course of many myopathies. Ability to swallow may be impaired because of weakness, inflammation, or dysfunction of the oropharyngeal, laryngeal, and esophageal musculature. Dysphagia may occur during the progression of disease regardless of whether the patient is properly treated. The presentation of signs of dysphagia can vary among patients because of differing patterns of weakness or incoordination of the facial muscles, lips, tongue, palate, pharyngeal constrictors, or smooth and striated muscles of the esophagus. Although the literature has focused on problems in the esophagus, scant attention has been paid to the oropharynx, which is often equally affected. Studies suggest that surgical myotomy and botulinum toxin injection may provide benefits for some patients with esophageal dysfunction. Although the condition is pervasive, there is little information on the incidence of dysphagia in muscular disorders. Because a major complication of dysphagia is aspiration, any sign of swallowing impairment demands medical attention and treatment.

Entities:  

Mesh:

Year:  1997        PMID: 9375277     DOI: 10.1097/00002281-199711000-00003

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  8 in total

Review 1.  The benefits and limitations of a physical training program in patients with inflammatory myositis.

Authors:  M Lawson Mahowald
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

2.  Cyclosporine A as treatment of esophageal involvement in dermatomyositis.

Authors:  Sumiyuki Mii; Shiro Niiyama; Mai Kusunoki; Satoru Arai; Kensei Katsuoka
Journal:  Rheumatol Int       Date:  2006-08-10       Impact factor: 2.631

3.  Esophageal contractions in patients with chronic progressive external ophthalmoplegia.

Authors:  Danielle Ramos Domenis; Paula Macedo Carvalho Issa Okubo; Cláudia Sobreira; Roberto Oliveira Dantas
Journal:  Dig Dis Sci       Date:  2011-03-12       Impact factor: 3.199

Review 4.  Idiopathic inflammatory myopathies: a treatment update.

Authors:  Chester V Oddis
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

5.  Diagnosis and treatment of post-extubation dysphagia: results from a national survey.

Authors:  Madison Macht; Tim Wimbish; Brendan J Clark; Alexander B Benson; Ellen L Burnham; André Williams; Marc Moss
Journal:  J Crit Care       Date:  2012-10-18       Impact factor: 3.425

6.  Deviation in the recovery of the lower limb and respiratory muscles of patients with polymyositis: a preliminary clinical study.

Authors:  Yuichi Nishikawa; Naohisa Hosomi; Hiroki Ueno; Takashi Kurashige; Kazuhide Ochi; Tetsuya Takahashi; Naoya Orita; Kazuyuki Ueda; Hirofumi Maruyama; Hiroaki Kimura; Masayasu Matsumoto
Journal:  J Phys Ther Sci       Date:  2016-09-29

Review 7.  The Value of Intravenous Immunoglobulin Therapy in Idiopathic Inflammatory Myositis in the Current Transformed Era of Biologics.

Authors:  Anjali Patwardhan
Journal:  Cureus       Date:  2020-02-19

8.  The Relationship Between Dysphagia and Pneumonia in Acute Stroke Patients: A Systematic Review and Meta-Analysis.

Authors:  Min Cheol Chang; Yoo Jin Choo; Kyung Cheon Seo; Seoyon Yang
Journal:  Front Neurol       Date:  2022-03-17       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.